ABP
Price
$4.73
Change
-$0.07 (-1.46%)
Updated
Dec 24 closing price
Capitalization
12.85M
Intraday BUY SELL Signals
EXOZ
Price
$12.47
Change
+$0.08 (+0.65%)
Updated
Dec 24 closing price
Capitalization
104.59M
Intraday BUY SELL Signals
Interact to see
Advertisement

ABP vs EXOZ

Header iconABP vs EXOZ Comparison
Open Charts ABP vs EXOZBanner chart's image
Abpro Holdings
Price$4.73
Change-$0.07 (-1.46%)
Volume$1.86K
Capitalization12.85M
eXoZymes
Price$12.47
Change+$0.08 (+0.65%)
Volume$6K
Capitalization104.59M
ABP vs EXOZ Comparison Chart in %
ABP
Daily Signal:
Gain/Loss:
EXOZ
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ABP vs. EXOZ commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABP is a Hold and EXOZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (ABP: $4.73 vs. EXOZ: $12.47)
Brand notoriety: ABP and EXOZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABP: 1% vs. EXOZ: 190%
Market capitalization -- ABP: $12.85M vs. EXOZ: $104.59M
ABP [@Biotechnology] is valued at $12.85M. EXOZ’s [@Biotechnology] market capitalization is $104.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABP’s FA Score shows that 1 FA rating(s) are green whileEXOZ’s FA Score has 0 green FA rating(s).

  • ABP’s FA Score: 1 green, 4 red.
  • EXOZ’s FA Score: 0 green, 5 red.
According to our system of comparison, ABP is a better buy in the long-term than EXOZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABP’s TA Score shows that 4 TA indicator(s) are bullish while EXOZ’s TA Score has 3 bullish TA indicator(s).

  • ABP’s TA Score: 4 bullish, 6 bearish.
  • EXOZ’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ABP is a better buy in the short-term than EXOZ.

Price Growth

ABP (@Biotechnology) experienced а -1.05% price change this week, while EXOZ (@Biotechnology) price change was +2.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXOZ($105M) has a higher market cap than ABP($12.8M). EXOZ YTD gains are higher at: -24.424 vs. ABP (-91.192). EXOZ has higher annual earnings (EBITDA): -8.72M vs. ABP (-10.1M). EXOZ has more cash in the bank: 5.1M vs. ABP (328K). ABP has less debt than EXOZ: ABP (147K) vs EXOZ (1.32M). ABP (0) and EXOZ (0) have equivalent revenues.
ABPEXOZABP / EXOZ
Capitalization12.8M105M12%
EBITDA-10.1M-8.72M116%
Gain YTD-91.192-24.424373%
P/E RatioN/AN/A-
Revenue00-
Total Cash328K5.1M6%
Total Debt147K1.32M11%
TECHNICAL ANALYSIS
Technical Analysis
ABPEXOZ
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
35%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
24%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 7 days ago
59%
Bullish Trend 4 days ago
90%
Declines
ODDS (%)
Bearish Trend 9 days ago
76%
Bearish Trend 9 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ABP
Daily Signal:
Gain/Loss:
EXOZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSGC0.25N/A
+2.01%
SafeSpace Global Corporation
ASCCF25.00N/A
N/A
Asics Corp.
NINOF11.10N/A
N/A
Nikon Corp.
BSLAF16.16N/A
N/A
Basler Ag
HSCT0.02N/A
N/A
HOOPS SCOUTING USA

ABP and

Correlation & Price change

A.I.dvisor tells us that ABP and NGNE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABP and NGNE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
-1.46%
NGNE - ABP
30%
Poorly correlated
-0.05%
QSI - ABP
27%
Poorly correlated
+6.50%
WHWK - ABP
26%
Poorly correlated
+1.51%
OMER - ABP
25%
Poorly correlated
+75.54%
ATYR - ABP
25%
Poorly correlated
+2.51%
More

EXOZ and

Correlation & Price change

A.I.dvisor tells us that EXOZ and CVKD have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXOZ and CVKD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXOZ
1D Price
Change %
EXOZ100%
+0.65%
CVKD - EXOZ
23%
Poorly correlated
+1.80%
ITRM - EXOZ
23%
Poorly correlated
-7.89%
PLUR - EXOZ
20%
Poorly correlated
-0.31%
ABP - EXOZ
15%
Poorly correlated
-1.46%
TLX - EXOZ
10%
Poorly correlated
+0.12%
More